Systems Oncology

1 follower


Systems Oncology is developing a new class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance.

Industries

Employees

11-50

Links

Org chart

Spyro Mousses
Co-Founder & Chief Executive Officer

Spyro Mousses

Collapse
Daniel D. Von Hoff
Co-Founder & Chief Clinical Strategist
Katy Marhenke
Director, Business Development Operations

Board & advisors

Chris Yoo
Director
Neil Torres
Director
Paul Hergenrother
Scientific Advisor
Stephen Munk
Scientific Advisor
Stephen Gately
Scientific Advisor
Mitesh Borad
Scientific Advisor
Scott C. Brun
Scientific Advisor
Joyce A. O’Shaughnessy
Scientific Advisor
Laszlo Radvanyi
Scientific Advisor
Lukas Bubendorf
Scientific Advisor
Sarah Shigdar
Scientific Advisor